# Problem Specification

> Grounding: abstract-only. Observations are limited to the provided abstract and metadata. Exact stratified counts, uncertainty intervals, and tables are not available from provided input.

## Observations

### O01: Dementia burden is framed as a global aging-linked public-health challenge
- **Statement**: The abstract states that, as global aging grows, dementia, particularly Alzheimer's disease, has become a major public-health challenge.
- **Evidence**: metadata.md Abstract: "As the global aging issue grows, dementia, particularly Alzheimer's disease (AD), has become a major public health challenge for everyone."
- **Implication**: A global longitudinal burden analysis is motivated by population aging and dementia's public-health relevance.

### O02: The study uses GBD data spanning 1990 to 2021 and forecasts to 2040
- **Statement**: The study analyzes Global Burden of Disease data from 1990 to 2021 and predicts future burdens to 2040.
- **Evidence**: metadata.md Abstract: "utilizes the Global Burden of Disease (GBD) database to analyze trends ... from 1990 to 2021 and to predict future burdens to 2040."
- **Implication**: The available evidence supports a retrospective trend analysis plus forward projection, but not exact model formulas or source table values.

### O03: Burden measures cover incidence, prevalence, and DALYs at global, regional, and national scales
- **Statement**: The abstract says the study examined global, regional, and national data on incidence, prevalence, and Disability-Adjusted Life Years.
- **Evidence**: metadata.md Abstract: "We examined global, regional, and national data ... focusing on incidence, prevalence, and Disability-Adjusted Life Years (DALYs)."
- **Implication**: The core problem is multi-scale epidemiological burden tracking rather than a single-country or single-endpoint analysis.

### O04: Burden increased, with highest incidence, prevalence, and DALYs observed in East Asia
- **Statement**: The abstract reports that global burden increased significantly and that East Asia had the highest incidence, prevalence, and DALYs.
- **Evidence**: metadata.md Abstract: "The global burden ... has significantly increased, with the highest incidence, prevalence, and DALYs observed in East Asia."
- **Implication**: Regional concentration is a planning target, but exact values and denominators are not available from provided input.

### O05: Forecasted age-standardized incidence and prevalence rates continue rising through 2040
- **Statement**: Bayesian age-period-cohort modeling projects age-standardized incidence and prevalence rates of 144.85 and 821.80 per 100,000 by 2040.
- **Evidence**: metadata.md Abstract: "projected to reach 144.85 and 821.80 per 100,000 respectively."
- **Implication**: Future burden is expected to remain a growing public-health pressure through 2040.

## Gaps

### G01: Public-health planning needs stratified burden forecasts
- **Statement**: The abstract argues for targeted interventions considering SDI, age, and gender, implying aggregate global burden is insufficient for planning.
- **Caused by**: O03, O04, O05
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

### G02: Exact reproducibility detail is unavailable from the abstract-only input
- **Statement**: The abstract names methods but does not provide GBD extraction settings, model formulas, software, uncertainty intervals, covariates, or full regional/national tables.
- **Caused by**: O02, O03
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

## Key Insight
- **Insight**: Combining GBD burden estimates, Joinpoint trend-change detection, age-period-cohort analysis, DALY decomposition, and Bayesian age-period-cohort forecasting can identify both historical trend shifts and future burden drivers for Alzheimer's disease and other dementias.
- **Derived from**: O02, O03, O05
- **Enables**: Targeted public-health interpretation by region, SDI quintile, age, and gender, within the limits of abstract-only evidence.

## Assumptions
- A1: GBD estimates are treated as the underlying epidemiological data source; exact GBD version settings are not available from provided input.
- A2: The abstract's reported trend-change years and projections summarize analyses performed in the full paper.
- A3: No claims are made about uncertainty intervals, national rankings beyond East Asia, or intervention effectiveness because those are not available from provided input.
